Thyroid Cancer

Part I: Differentiated Thyroid Cancer: Initial Management.- 1.A Patient with a Single Thyroid Nodule Suspicious for Follicular Neoplasm According to the Bethesda System for Reporting Thyroid Cytopathology: Molecular Evaluation.- 2.A Young Patient with Intrathyroidal Papillary Thyroid Cancer and Family History of Differentiated Thyroid Cancer.- 3.A Case of a Small (1-2 cm) Papillary Thyroid Cancer in a Young Patient: Lobectomy Versus Total Thyroidectomy.- 4.A Patient with Papillary Microcarcinoma Undergoing Active Surveillance.- 5.Completion Thyroidectomy in a Patient with Low-Risk Papillary Cancer.- 6.A Papillary Thyroid Cancer with Minimal Extra-thyroidal Extension.- 7.A small Papillary Thyroid Cancer with angioinvasion.- 8.A patient with a pathological diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP).- 9.Papillary Thyroid Cancer with Central Neck Lymph Node Metastases.- 10.A Patient with a Large Minimally Invasive FollicularThyroid Cancer.- 11.A Child with Papillary Thyroid Cancer and Locally Advanced Disease but No Distant Metastasis.- Part II: Differentiated Thyroid Cancer: Postoperative Follow-Up.- 12.A Patient with Papillary Thyroid Cancer and Biochemical Evidence of Disease at the One-Year Follow-Up Visit.- 13.A Patient with Low Risk Papillary Thyroid Cancer Who Has Undergone a Lobectomy: Monitoring for Recurrent Disease and Assessment of Thyroid Function.-14.A Patient with Papillary Thyroid Carcinoma and Biochemical Evidence of Disease at Follow-Up Visits with Increasing Serum Tg Values at the Follow-Up Assessments.- 15.A Young Patient with Recurrent Lymph Node Involvement: Imaging, Cytology, and Thyroglobulin Washout.- Part III: Differentiated Thyroid Cancer: Special Issues.- 16.Papillary Thyroid Carcinoma Diagnosed During Pregnancy.- 17.Risks of Thyroid Hormone Suppression for Differentiated Thyroid Cancer in the Elderly.- 18.A Case with Postsurgical Hypoparathyroidism.- 19.A Patient with Postsurgical Recurrent Laryngeal Nerve Damage and Nerve Monitoring.- Part IV: Differentiated Thyroid Cancer: Managing higher risk patients.- 20.A Case of Papillary Thyroid Cancer Without Aggressive Histological Features with Nodal Metastases Detected During Follow-Up in a Younger Patient.- 21.A Patient with a Large Hürthle Cell Carcinoma of the Thyroid and Nodal Metastases.- 22.A Case of a Large, Invasive PTC with Gross Residual Disease (pT4) After Surgery.- 23.A Patient with Papillary Carcinoma of the Thyroid with Elevated Serum Thyroglobulin but Negative Imaging Studies.- 24.A Young Child with Papillary Thyroid Cancer and Metastatic Pulmonary Disease: Role of Radioactive Iodine Therapy in Children.- 25.A Patient with Bone Metastases from Follicular Carcinoma of the Thyroid.- 26.Radioiodine Therapy in Lactating Women with Higher-Risk Differentiated Thyroid Cancer.- Part V: Differentiated Thyroid Cancer: Beyond Radioactive Iodine Therapy.- 27.A Case of a Patient with Radioactive Iodine Refractory Differentiated Thyroid Cancer with Progressive Neck Disease (Latero-cervical Lymph Nodes) and Stable, Small Lung Metastases.- 28. A Case of a Patient with High Risk Papillary Thyroid Cancer With Gross Residual Disease after Initial Thyroidectomy: Role of External Beam Radiotherapy.- 29.RAI-Refractory Differentiated Thyroid Cancer with Multiple Organ Progressive Disease.- 30.RAI-Refractory Differentiated Thyroid Cancer and Lung Lesions Causing Bleeding.- 31.A Patient with Follicular Thyroid Cancer and a Painful Bone Metastases at Risk for Pathologic Fracture.- 32.Differentiated Thyroid Cancer and Brain Metastases.- 33.RAI-Refractory, Advanced Differentiated Thyroid Cancer Receiving Tyrosine Kinase Inhibitor Treatment: Checking for Drug-Drug Interactions.- Part VI: Medullary Thyroid Cancer.- 34.Management of Postoperative Hypercalcitoninemia in MTC.- 35.A Patient with Metastatic Medullary Thyroid Carcinoma (MTC) and Tumor-Related Diarrhea.- 36.Clinical Management of a Patient with a Locally Recurrent Medullary Thyroid Cancer and Asymptomatic Slowly Progressing Distant Metastases.- 37.A Patient with an Advanced Medullary Thyroid Cancer and Progressive, Symptomatic Distant Metastases: When to Start Systemic Therapy.- 38.Medical Treatment Decision-Making for Advanced, Progressive Medullary Thyroid Cancer.- 39.Screening Leading to Diagnosis of C-Cell Hyperplasia.- 40.Increased Basal Calcitonin in Nodular Goiter: Is It Micromedullary Thyroid Cancer?.- 41.Timing and Extent of Surgery for a Pediatric Patient with Hereditary MTC and Positive Screening for the S891A RET Mutation.- Part VII: Anaplastic Thyroid Cancer.- 42.Anaplastic Thyroid Cancer: Surgery or Not in Locally Advanced Disease.- 43.A Patient with BRAFV600E-mutated Anaplastic Thyroid Cancer with Metastatic Disease